|
Dr. Reddy's Laboratories Ltd.
|
Balance Sheet
|
|
|
You can view the
Balance Sheet
for the last 5 years.
|
Market Cap. (Rs.)
|
95970.71 Cr.
|
P/BV
|
3.12
|
Book Value (Rs.)
|
368.50
|
|
52 Week High/Low (Rs.)
|
1421/1020
|
FV/ML
|
1/1
|
P/E(X)
|
17.21
|
|
Bookclosure
|
28/10/2024
|
EPS (Rs.)
|
66.84
|
Div Yield (%)
|
0.70
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| No. of Equity Shares (in Lacs) | 1668.18 | 1665.28 | 1664.26 | 1663.01 | 1660.66 |
| | | | | | |
| EQUITIES AND LIABILITIES | | | | | |
| SHAREHOLDER'S FUNDS | | | | | |
| Equity Share Capital | 83.40 | 83.30 | 83.20 | 83.20 | 83.10 |
| Total Share Capital | 83.40 | 83.30 | 83.20 | 83.20 | 83.10 |
| | | | | | |
| Reserves and Surplus | 28171.40 | 23202.80 | 19129.20 | 17558.50 | 15515.70 |
| Total Reserves and Surplus | 28171.40 | 23202.80 | 19129.20 | 17558.50 | 15515.70 |
| Total Shareholders Funds | 28254.80 | 23286.10 | 19212.40 | 17641.70 | 15598.80 |
| | | | | | |
| NON-CURRENT LIABILITIES | | | | | |
| Long Term Borrowings | 380.00 | 0.00 | 380.00 | 380.00 | 130.40 |
| Deferred Tax Liabilities [Net] | 84.10 | 76.00 | 1.40 | 28.90 | 2.00 |
| Other Long Term Liabilities | 533.00 | 331.00 | 361.50 | 411.60 | 205.50 |
| Long Term Provisions | 23.90 | 19.90 | 25.80 | 50.80 | 74.50 |
| Total Non-Current Liabilities | 1021.00 | 426.90 | 768.70 | 871.30 | 412.40 |
| | | | | | |
| CURRENT LIABILITIES | | | | | |
| Short Term Borrowings | 1272.30 | 1119.00 | 2708.20 | 2314.50 | 1653.20 |
| Trade Payables | 2614.40 | 2268.40 | 2266.20 | 1810.90 | 1524.80 |
| Other Current Liabilities | 5009.30 | 4532.20 | 4204.80 | 3476.90 | 3569.20 |
| Short Term Provisions | 692.00 | 652.50 | 586.60 | 501.50 | 466.90 |
| Total Current Liabilities | 9588.00 | 8572.10 | 9765.80 | 8103.80 | 7214.10 |
| | | | | | |
| Total Capital And Liabilities | 38863.80 | 32285.10 | 29746.90 | 26616.80 | 23225.30 |
| | | | | | |
| ASSETS | | | | | |
| NON-CURRENT ASSETS | | | | | |
| Tangible Assets | 6248.70 | 5654.20 | 4886.90 | 4732.20 | 4777.90 |
| Intangible Assets | 3626.80 | 3017.50 | 2687.30 | 2913.60 | 1581.10 |
| Capital Work-In-Progress | 1351.00 | 975.20 | 1279.60 | 953.90 | 436.40 |
| Intangible Assets Under Development | 68.30 | 54.90 | 13.80 | 611.20 | 1098.70 |
| Fixed Assets | 11294.80 | 9701.80 | 8867.60 | 9210.90 | 7894.10 |
| Goodwill On Consolidation | 550.10 | 547.40 | 547.30 | 559.90 | 491.30 |
| Non-Current Investments | 525.50 | 536.20 | 598.60 | 833.30 | 309.10 |
| Deferred Tax Assets [Net] | 1057.80 | 705.20 | 1277.00 | 1068.60 | 1219.90 |
| Other Non-Current Assets | 630.30 | 369.00 | 674.10 | 393.80 | 711.80 |
| Total Non-Current Assets | 14058.50 | 11859.60 | 11964.60 | 12066.50 | 10626.20 |
| | | | | | |
| | | | | | |
| CURRENT ASSETS | | | | | |
| Current Investments | 4405.00 | 4449.60 | 2017.30 | 1378.50 | 2368.70 |
| Inventories | 6355.20 | 4867.00 | 5088.40 | 4541.20 | 3506.70 |
| Trade Receivables | 8029.80 | 7248.50 | 6676.40 | 4964.10 | 5027.80 |
| Cash And Cash Equivalents | 1727.70 | 1730.20 | 2419.20 | 2078.80 | 205.30 |
| OtherCurrentAssets | 4287.60 | 2130.20 | 1581.00 | 1587.70 | 1490.60 |
| Total Current Assets | 24805.30 | 20425.50 | 17782.30 | 14550.30 | 12599.10 |
| | | | | | |
| Total Assets | 38863.80 | 32285.10 | 29746.90 | 26616.80 | 23225.30 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
| Contingent Liabilities | 2091.80 | 997.40 | 936.80 | 1077.40 | 1040.60 |
| | | | | | |
| BONUS DETAILS | | | | | |
| Bonus Equity Share Capital | 55.87 | 55.87 | 55.87 | 55.87 | 55.87 |
| | | | | | |
| NON-CURRENT INVESTMENTS | | | | | |
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 30.30 |
| Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 2371.20 |
